ARWR Historical PE Ratio image   This ARWR PE ratio history page last updated 11/30/2022
ARWR Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2022
11/28/2022
28.00-0.81-3.24NA
Q3 2022
8/4/2022
46.13-0.68-2.72NA
Q2 2022
5/10/2022
34.290.411.6420.9
Q1 2022
2/2/2022
52.63-0.60-2.40NA
Q4 2021
11/22/2021
69.28-0.61-2.44NA
Q3 2021
8/5/2021
68.05-0.29-1.16NA
Q2 2021
5/4/2021
66.48-0.26-1.04NA
Q1 2021
2/4/2021
83.92-0.20-0.80NA
Q4 2020
11/23/2020
68.20-0.48-1.92NA
Q3 2020
8/5/2020
43.56-0.13-0.52NA
Q2 2020
5/7/2020
35.13-0.20-0.80NA
Q1 2020
2/5/2020
43.72-0.03-0.12NA
Q4 2019
11/25/2019
56.990.110.44129.5
Q3 2019
8/5/2019
27.240.210.8432.4
Q2 2019
5/8/2019
18.330.240.9619.1
Q1 2019
2/7/2019
13.300.130.5225.6
Q4 2018
12/11/2018
13.62-0.12-0.48NA
Q3 2018
8/7/2018
15.10-0.18-0.72NA
Q2 2018
5/8/2018
7.75-0.18-0.72NA
Q1 2018
2/9/2018
5.59-0.18-0.72NA
Q4 2017
12/12/2017
3.55-0.15-0.60NA
Q3 2017
8/3/2017
1.70-0.07-0.28NA
Q2 2017
5/3/2017
1.56-0.08-0.32NA
Q1 2017
2/6/2017
1.88-0.17-0.68NA
Q4 2016
12/14/2016
1.27-0.34-1.36NA
Q3 2016
8/9/2016
6.39-0.32-1.28NA
Q2 2016
5/10/2016
5.72-0.35-1.40NA
Q1 2016
2/9/2016
3.18-0.32-1.28NA
Q4 2015
12/14/2015
5.69-0.41-1.64NA
Q3 2015
8/4/2015
6.03-0.27-1.08NA
Q2 2015
5/11/2015
6.69-0.51-2.04NA
Q1 2015
2/9/2015
6.21-0.41-1.64NA
Q4 2014
11/25/2014
5.84-0.42-1.68NA
Q3 2014
8/12/2014
13.00-0.22-0.88NA
Q2 2014
5/6/2014
10.220.311.248.2
Q1 2014
4/4/2014
16.210.281.1214.5
FY 2013
12/18/2013
9.14-1.30-5.20NA
Q3 2013
8/7/2013
4.34-0.23-0.92NA
Q2 2013
5/9/2013
2.01-0.41-1.64NA
Q1 2013
2/4/2013
1.94-0.28-1.12NA
Q4 2012
12/20/2012
2.11-0.43-1.72NA
ARWR PE History Chart
PeriodPriceGAAPTTMPE
Q4 2022
11/28/2022
28.00-0.81-1.68NA
Q3 2022
8/4/2022
46.13-0.68-1.48NA
Q2 2022
5/10/2022
34.290.41-1.09NA
Q1 2022
2/2/2022
52.63-0.60-1.76NA
Q4 2021
11/22/2021
69.28-0.61-1.36NA
Q3 2021
8/5/2021
68.05-0.29-1.23NA
Q2 2021
5/4/2021
66.48-0.26-1.07NA
Q1 2021
2/4/2021
83.92-0.20-1.01NA
Q4 2020
11/23/2020
68.20-0.48-0.84NA
Q3 2020
8/5/2020
43.56-0.13-0.25NA
Q2 2020
5/7/2020
35.13-0.200.09390.3
Q1 2020
2/5/2020
43.72-0.030.5382.5
Q4 2019
11/25/2019
56.990.110.6982.6
Q3 2019
8/5/2019
27.240.210.4659.2
Q2 2019
5/8/2019
18.330.240.07261.9
Q1 2019
2/7/2019
13.300.13-0.35NA
Q4 2018
12/11/2018
13.62-0.12-0.66NA
Q3 2018
8/7/2018
15.10-0.18-0.69NA
Q2 2018
5/8/2018
7.75-0.18-0.58NA
Q1 2018
2/9/2018
5.59-0.18-0.48NA
Q4 2017
12/12/2017
3.55-0.15-0.47NA
Q3 2017
8/3/2017
1.70-0.07-0.66NA
Q2 2017
5/3/2017
1.56-0.08-0.91NA
Q1 2017
2/6/2017
1.88-0.17-1.18NA
Q4 2016
12/14/2016
1.27-0.34-1.33NA
Q3 2016
8/9/2016
6.39-0.32-1.40NA
Q2 2016
5/10/2016
5.72-0.35-1.35NA
Q1 2016
2/9/2016
3.18-0.32-1.51NA
Q4 2015
12/14/2015
5.69-0.41-1.60NA
Q3 2015
8/4/2015
6.03-0.27-1.61NA
Q2 2015
5/11/2015
6.69-0.51-1.56NA
Q1 2015
2/9/2015
6.21-0.41-0.74NA
Q4 2014
11/25/2014
5.84-0.42-0.05NA
Q3 2014
8/12/2014
13.00-0.22-0.93NA
Q2 2014
5/6/2014
10.220.31-0.94NA
Q1 2014
4/4/2014
16.210.28-1.66NA
FY 2013
12/18/2013
9.14-1.30-2.22NA
Q3 2013
8/7/2013
4.34-0.23-1.35NA
Q2 2013
5/9/2013
2.01-0.41NANA
Q1 2013
2/4/2013
1.94-0.28NANA
Q4 2012
12/20/2012
2.11-0.43NANA
Quotes delayed 20 minutes

Email EnvelopeFree ARWR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Arrowhead Pharmaceuticals (ARWR) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ASMB PE Ratio History
ASRT PE Ratio History
ATEC PE Ratio History
ATHA PE Ratio History
ATHX PE Ratio History
ATIP PE Ratio History
ATNF PE Ratio History
ATNX PE Ratio History
ATOS PE Ratio History
ATRA PE Ratio History
How should the ARWR historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Arrowhead Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ARWR Historical PE Ratio page.

What is the average historical PE for ARWR based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ARWR historical PE ratio using the annualized quarterly earnings method works out to 35.7.

What is the average historical PE for ARWR based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ARWR historical PE ratio using the TTM earnings method works out to 175.3.

On this page we presented the ARWR Historical PE Ratio information for Arrowhead Pharmaceuticals' stock. The average ARWR historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 35.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ARWR historical PE based on this TTM earnings result method is 175.3. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ARWR historical PE result, against the recent PE: when this page was posted on 11/29/2022, the most recent closing price for ARWR had been 29.99, and the most recent quarterly earnings result, annualized, was 1.64. Meanwhile, the most recent TTM earnings summed to 0.09. From these numbers, we calculate the recent ARWR PE on 11/29/2022 based on annualized quarterly EPS was 18.3. Based on ARWR's history, that recent PE is low relative to the historical average, with the recent PE 48.7% lower than the historical average PE across our data set for Arrowhead Pharmaceuticals. Looking at the recent ARWR PE on 11/29/2022 based on TTM EPS, we calculate the ratio at 333.2. Based on ARWR's history, that recent PE is elevated relative to the historical average, with the recent PE 90.1% higher than the historical average PE across our Arrowhead Pharmaceuticals data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on ARWR or any other given stock, valuation analysis for ARWR can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Arrowhead Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ARWR. Thanks for visiting, and the next time you need to research ARWR Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: KALU shares outstanding history, Institutional Holders of RUSS, Funds Holding FXF.

 

ARWR Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.